Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-17 Sale |
2021-03-18 8:44 pm |
Neoleukin Therapeutics Inc. | NLTX | Ho Robert Chief Financial Officer |
6,497 | $11.01 | $71,556 | 71,503 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-06 Option Award |
2023-03-08 4:58 pm |
N/A 2032-03-24 |
Third Harmonic Bio Inc. | THRD | Ho Robert Chief Financial Officer |
598,955 | $0 | 598,955 (Direct) |
View |
| 2022-10-25 Option Award |
2022-10-27 4:51 pm |
N/A 2032-10-24 |
Third Harmonic Bio Inc. | THRD | Ho Robert Chief Financial Officer |
95,000 | $0 | 95,000 (Direct) |
View |
Ownership |
2022-09-14 6:11 pm |
N/A 2032-03-24 |
Third Harmonic Bio Inc. | THRD | Ho Robert Chief Financial Officer |
0 | $0 | 367,955 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 4:36 pm |
N/A N/A |
Neoleukin Therapeutics Inc. | NLTX | Ho Robert Chief Financial Officer |
70,000 | $0 | 70,000 (Direct) |
View |
| 2021-08-03 Option Award |
2021-08-05 4:14 pm |
N/A 2031-08-03 |
Neoleukin Therapeutics Inc. | NLTX | Ho Robert Chief Financial Officer |
190,000 | $0 | 190,000 (Direct) |
View |
| 2021-03-16 Exercise |
2021-03-18 8:44 pm |
N/A N/A |
Neoleukin Therapeutics Inc. | NLTX | Ho Robert Chief Financial Officer |
25,000 | $0 | 71,503 (Direct) |
View |
| 2020-08-10 Option Award |
2020-08-12 4:10 pm |
N/A 2030-08-10 |
Neoleukin Therapeutics Inc. | NLTX | Ho Robert Chief Financial Officer |
90,000 | $0 | 90,000 (Direct) |
View |